- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06046326
Evaluate the Effectiveness of a Virtual Community of Practice
Evaluate the Effectiveness of a Virtual Community of Practice Via a Web-based Application Versus Individual and Self-administered Online Education to Improve the Activation of Middle-aged People With Multimorbidity.
Objective: To evaluate and compare the effectiveness and cost-effectiveness of a Virtual Community of Practice (VCoP) via a web-based application versus individual and self-administered online education to improve the activation of middle-aged people with multimorbidity.
Design: Randomized controlled pragmatic clinical trial with two parallel arms and 18 months follow-up.
Setting: Primary health centres and hospitals (Catalonia, Madrid, and the Canary Islands). Population: Middleaged people (30-60 years old) with multimorbidity (≥=2 chronic diseases). Sample size: 240 patients.
Randomization: all participants will be randomly assigned to the intervention (VCoP) or the active control group. Data analysis will be blinded to intervention allocation. Intervention: The intervention group will be offered participation for 12 months in a VCoP based on a gamified web-based application. The control group will receive individual, content-focused education through a web platform that will cover the same topics as the VCoP but will be self-administered and without social interaction within the platform.
Measurements: The main variable will be measured using the Patient Activation Measure (PAM) questionnaire at baseline, 6, 12 and 18 months. Secondary variables: participant sociodemographics, depression (PHQ-9), anxiety (HADS-A), treatment burden (TBQ), quality of life (EQ-5D-5L), variables related to the use of health resources and to the use of the VCoP. Analysis: Mixed-effects linear regression will be used to determine the effects of the VCoP on the changes in patient activation. Scores at baseline, 6, 12 and 18 months will be included as a fixed effect variable, and the patient and health professional as random effect variables. Analyses will be performed on an intention-to-treat basis. An economic evaluation will be carried out to analyze the cost-effectiveness of the VCoP compared to active control, from the National Health System and social perspectives.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objective: To evaluate and compare the effectiveness and cost-effectiveness of a Virtual Community of Practice (VCoP) via a web-based application versus individual and self-administered online education to improve the activation of middle-aged people with multimorbidity.
Design: Randomized controlled pragmatic clinical trial with two parallel arms and 18 months follow-up.
Setting: Primary health centres and hospitals (Catalonia, Madrid, and the Canary Islands). Population:
Inclusion criteria:
- Age between 30 and 60 years
- diagnosis of ≥ 2 chronic diseases
- have a computer with an Internet connection or another mobile device (tablet or smartphone)
- be able to follow the requirements of the study have signed the informed consent
Exclusion criteria:
- Low probability of cooperation in the study
- with a terminal illness, physical or mental disability that prevents answering the questionnaires correctly
- Sample size: 240 patients.
Randomization: all participants will be randomly assigned to the intervention (VCoP) or the active control group. Data analysis will be blinded to intervention allocation.
Intervention: The intervention group will be offered participation for 12 months in a VCoP based on a web-based application. The control group will receive individual, content-focused education through a web platform that will cover the same topics as the VCoP but will be self-administered and without social interaction within the platform.
Measurements:
participant sociodemographics variables The main variable will be measured using the Patient Activation Measure (PAM) questionnaire at baseline, 6, 12 and 18 months. It consists of 13 items that assess people´s Knowledge, skills and confidence in self-care for their health and medical care, measured using a 1-4 likert scale with a total score that is transferred to a scale between 0 and 100.
Secondary variables:
Patient Health Questionnaire at baseline, 6, 12 and 18 months It is a short instrument, designed to be self-administered. It consists of 9 items that evaluate the presence of depressive symptoms present in the last 2 weeks. Each item has a severity index: 0 = "never", 1 = "some days", 2 = "more than half of the days" and 3 = "almost every day". The puntuation is between 0 and 27 (worse puntuation).
Hospital Anxiety and Depression Scale at baseline, 6, 12 and 18 months It is a 14-item questionnaire composed of two sub-scales (HAD-A: anxiety and HAD-D: depression), of 7 items each that are scored from 0 to 3. The puntuation is between 0 and 21 (worse puntuation). The authors recommend points of 8 for possible cases and >10 for probable cases on both subscales.
Treatment Burden Questionnaire at baseline, 6, 12 and 18 months It is a questionnaire of 13 items that uses a Likert scale that ranges from 0 (not a problem) to 20 (it is an important problem) and that assesses the burden related to taking medication, self-care, laboratory tests, medical appointments, the need for organization, administrative tasks, compliance with diet and physical activity and the social impact of treatment. The puntuation is between 0 and 260 (worse puntuation).
European quality of life. Euroqol-5D at baseline, 6, 12 and 18 months Assesses health-related quality of life (HRQoL) both in the general population and in groups of patients with different pathologies. It comprises 5 dimensions (mobility, self-care, activities of daily living, pain/discomfort, and anxiety/depression). Each dimension has 3 items that are scored from 1, no problems, to 3, many problems. There is a visual analogue scale that scores from 0 (worst health status imaginable) to 100 (best health status imaginable)
Analysis: Mixed-effects linear regression will be used to determine the effects of the VCoP on the changes in patient activation. Scores at baseline, 6, 12 and 18 months will be included as a fixed effect variable, and the patient and health professional as random effect variables.
Analyses will be performed on an intention-to-treat basis. An economic evaluation will be carried out to analyze the cost-effectiveness of the VCoP compared to active control, from the National Health System and social perspectives.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Middleagedpeople (30-60 years old)
- with multimorbidity (≥=2 chronic diseases).
Exclusion Criteria:
- Low probability of cooperation in the study
- situation of transients or displaced persons, institutionalized, with some terminal illness, physical or mental disability that prevents them from answering the questionnaires correctly.
- When the contact telephone number/email is not available in the CAP/hospital database.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: virtual community of practice
The intervention group will be offered participation for 12 months in a VCoP based ona gamified web-based application.
|
The intervention group will be offered participation for 12 months in a VCoP based ona gamified web-based application.
|
No Intervention: control group
The control group will receive individual, content-focused education through a web platform that will cover the same topics as the VCoP but will be self-administered and without social interaction within theplatform.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the Patient Activation Measure (PAM)
Time Frame: Baseline
|
It consists of 13 items that assess people's knowledge, skills, and confidence in self-care for their health and medical care, measured using a 1-4 Likert scale with a total score that is transferred to a scale between 0 and 100.
|
Baseline
|
the Patient Activation Measure (PAM)
Time Frame: 12 months
|
It consists of 13 items that assess people's knowledge, skills, and confidence in self-care for their health and medical care, measured using a 1-4 Likert scale with a total score that is transferred to a scale between 0 and 100.
|
12 months
|
the Patient Activation Measure (PAM)
Time Frame: 18 months
|
It consists of 13 items that assess people's knowledge, skills, and confidence in self-care for their health and medical care, measured using a 1-4 Likert scale with a total score that is transferred to a scale between 0 and 100.
|
18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Health Questionnaire-9
Time Frame: Baseline
|
It is a short instrument, designed to be self-administered.
It consists of 9 items that evaluate the presence of depressive symptoms present in the last 2 weeks.
Each item has a severity index: 0 = "never", 1 = "some days", 2 = "more than half of the days" and 3 = "almost every day".
The puntuation is between 0 and 27 (worse puntuation).
|
Baseline
|
Patient Health Questionnaire-9
Time Frame: 12 months
|
It is a short instrument, designed to be self-administered.
It consists of 9 items that evaluate the presence of depressive symptoms present in the last 2 weeks.
Each item has a severity index: 0 = "never", 1 = "some days", 2 = "more than half of the days" and 3 = "almost every day".
The puntuation is between 0 and 27 (worse puntuation).
|
12 months
|
Patient Health Questionnaire-9
Time Frame: 18 months
|
It is a short instrument, designed to be self-administered.
It consists of 9 items that evaluate the presence of depressive symptoms present in the last 2 weeks.
Each item has a severity index: 0 = "never", 1 = "some days", 2 = "more than half of the days" and 3 = "almost every day".
The puntuation is between 0 and 27 (worse puntuation).
|
18 months
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: Baseline
|
It is a 14-item questionnaire composed of two sub-scales (HAD-A: anxiety and HAD-D: depression), of 7 items each that are scored from 0 to 3. The puntuation is between 0 and 21 (worse puntuation).
The authors recommend points of 8 for possible cases and >10 for probable cases on both subscales.
|
Baseline
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: 12 months
|
It is a 14-item questionnaire composed of two sub-scales (HAD-A: anxiety and HAD-D: depression), of 7 items each that are scored from 0 to 3. The puntuation is between 0 and 21 (worse puntuation).
The authors recommend points of 8 for possible cases and >10 for probable cases on both subscales.
|
12 months
|
Hospital Anxiety and Depression Scale (HADS)
Time Frame: 18 months
|
It is a 14-item questionnaire composed of two sub-scales (HAD-A: anxiety and HAD-D: depression), of 7 items each that are scored from 0 to 3. The puntuation is between 0 and 21 (worse puntuation).
The authors recommend points of 8 for possible cases and >10 for probable cases on both subscales.
|
18 months
|
Treatment Burden Questionnaire-TBQ
Time Frame: Baseline
|
It is a questionnaire of 13 items that uses a Likert scale that ranges from 0 (not a problem) to 20 (it is an important problem) and that assesses the burden related to taking medication, self-care, laboratory tests, medical appointments, the need for organization, administrative tasks, compliance with diet and physical activity and the social impact of treatment.
The puntuation is between 0 and 260 (worse puntuation).
on the self-administered Treatment Burden Questionnaire - TBQ
|
Baseline
|
Treatment Burden Questionnaire-TBQ
Time Frame: 12 months
|
It is a questionnaire of 13 items that uses a Likert scale that ranges from 0 (not a problem) to 20 (it is an important problem) and that assesses the burden related to taking medication, self-care, laboratory tests, medical appointments, the need for organization, administrative tasks, compliance with diet and physical activity and the social impact of treatment.
The puntuation is between 0 and 260 (worse puntuation).
on the self-administered Treatment Burden Questionnaire - TBQ
|
12 months
|
Treatment Burden Questionnaire-TBQ
Time Frame: 18 months
|
It is a questionnaire of 13 items that uses a Likert scale that ranges from 0 (not a problem) to 20 (it is an important problem) and that assesses the burden related to taking medication, self-care, laboratory tests, medical appointments, the need for organization, administrative tasks, compliance with diet and physical activity and the social impact of treatment.
The puntuation is between 0 and 260 (worse puntuation).
on the self-administered Treatment Burden Questionnaire - TBQ
|
18 months
|
European quality of life-5 dimensions. E5-5D-5L questionnaire
Time Frame: Baseline
|
Assesses health-related quality of life (HRQoL) both in the general population and in groups of patients with different pathologies.
It comprises 5 dimensions (mobility, self-care, activities of daily living, pain/discomfort, and anxiety/depression).
Each dimension has 3 items that are scored from 1, no problems, to 3, many problems.
There is a visual analogue scale that scores from 0 (worst health status imaginable) to 100 (best health status imaginable)
|
Baseline
|
European quality of life-5 dimensions. E5-5D-5L questionnaire
Time Frame: 12 months
|
Assesses health-related quality of life (HRQoL) both in the general population and in groups of patients with different pathologies.
It comprises 5 dimensions (mobility, self-care, activities of daily living, pain/discomfort, and anxiety/depression).
Each dimension has 3 items that are scored from 1, no problems, to 3, many problems.
There is a visual analogue scale that scores from 0 (worst health status imaginable) to 100 (best health status imaginable)
|
12 months
|
European quality of life-5 dimensions. E5-5D-5L questionnaire
Time Frame: 18 months
|
Assesses health-related quality of life (HRQoL) both in the general population and in groups of patients with different pathologies.
It comprises 5 dimensions (mobility, self-care, activities of daily living, pain/discomfort, and anxiety/depression).
Each dimension has 3 items that are scored from 1, no problems, to 3, many problems.
There is a visual analogue scale that scores from 0 (worst health status imaginable) to 100 (best health status imaginable)
|
18 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PI22/01124
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Diseases
-
American Academy of Family PhysiciansUniversity of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaboratorsCompletedChronic Kidney Disease | Chronic Renal Insufficiency | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney Insufficiency, ChronicUnited States
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsRecruitingChronic Disease | Chronic Conditions, Multiple | Chronic ConditionDenmark
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsActive, not recruitingChronic Conditions, Multiple | Chronic ConditionDenmark
-
University of the State of Santa CatarinaUnknownKidney Diseases | Chronic Kidney Diseases | Hemodialysis | Chronic Renal Insufficiency | Renal Dialysis | Chronic Kidney Insufficiency | Chronic Renal DiseasesBrazil
-
Radboud University Medical CenterRecruitingChronic Conditions, Multiple | Chronic ConditionNetherlands
-
University of Alabama at BirminghamRecruitingDisability Physical | Chronic Conditions, Multiple | Chronic ConditionUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
Documenting Hope ProjectRecruiting
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Korean Society of HematologyNot yet recruitingChronic Myeloid Leukemia, Chronic Phase
Clinical Trials on virtual community of practice
-
Avedis Donabedian Research InstituteServicio Canario de Salud; Gerencia de Atención Primaria, MadridUnknown
-
VA Palo Alto Health Care SystemCompleted
-
Gerencia de Atención Primaria, MadridServicio Canario de Salud; Avedis Donabedian Research InstituteCompletedIschemic Heart Disease ChronicSpain
-
Tzu Chi UniversityNational Science Council, TaiwanCompletedNormal Pregnancy
-
Martha BiddleNational Institute for Occupational Safety and Health (NIOSH/CDC)CompletedDepression | Occupational StressUnited States
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruiting
-
University of Colorado, DenverCompleted
-
Oregon Health and Science UniversityNot yet recruitingWounds and Injuries | Pain Management | Ergonomics
-
Indiana UniversityNational Institute of Mental Health (NIMH); University of Florida; Eskenazi HealthCompletedMental Illness | Shared Decision MakingUnited States